**Robust IPO momentum in 2026 has already produced more than 100 priced offerings raising over $146 billion through mid-September, with additional listings scheduled before year-end.** Multiple deals are set to price in the final days of September, including Oura and Accelevation, while the broader pipeline features AI-infrastructure, biotech, and consumer names. Activity reflects improved risk appetite relative to prior years, supported by equity valuations and selective institutional demand, though tempered by elevated Treasury yields and concerns over AI spending sustainability. Trader sentiment on additional IPOs before 2027 will likely hinge on near-term performance of these offerings, macroeconomic data releases, and any shifts in monetary policy expectations that influence equity issuance windows.